Cadrenal Therapeutics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.
/ 
Frequently asked questions
To buy Cadrenal Therapeutics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Cadrenal Therapeutics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Cadrenal Therapeutics Inc. is CVKD:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Cadrenal Therapeutics Inc. has its primary listing on NASDAQ (Small cap). You can trade Cadrenal Therapeutics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Cadrenal Therapeutics Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Cadrenal Therapeutics Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Cadrenal Therapeutics Inc..